COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04381962


Column Value
Trial registration number NCT04381962
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : May 8, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Paul Little, MD PhD

Contact
Last imported at : May 8, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Lucy Cureton, atomic2@ndorms.ox.ac.uk (PI email not reported)

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-05-11

Recruitment status
Last imported at : May 8, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

inclusion criteria: - male or female, aged at least 18 years - assessed by the attending clinical team as appropriate for initial ambulatory (outpatient) management - a clinical diagnosis of highly-probable covid-19 infection (diagnosis by the attending clinical team) - no medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial - able to understand written english (for the information and consent process) and be able to give informed consent

Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

- known hypersensitivity to any macrolide including azithromycin, ketolide antibiotic, or the excipients including an allergy to soya or peanuts. - known fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase-insufficiency - currently on a macrolide antibiotic (clarithromycin, azithromycin, erythromycin, telithromycin, spiramycin) - on any ssri (selective serotonin reuptake inhibitor) - elevated cardiac troponin at initial assessment suggestive of significant myocarditis (if clinically the clinical team have felt it appropriate to check the patient's troponin levels) - evidence of qtc prolongation: qtc>480ms - significant electrolyte disturbance (e.g. hypokalaemia k+<3.5 mmol/l) - clinically relevant bradycardia (p<50 bpm), non-sustained ventricular tachycardia or unstable severe cardiac insufficiency - currently on hydroxychloroquine or chloroquine

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

University of Oxford

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

19

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

United Kingdom

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Mild disease at enrollment

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

1: Mild disease at enrollment

Total sample size
Last imported at : May 8, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

298

primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Proportion progressing to respiratory failure or death (all clinically-diagnosed participants)

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 3

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 165, "treatment_name": "Azithromycin", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]